Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?

Detalles Bibliográficos
Autores principales: Marcec, Robert, Likic, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307409/
https://www.ncbi.nlm.nih.gov/pubmed/35869361
http://dx.doi.org/10.1007/s40262-022-01154-x
_version_ 1784752756839415808
author Marcec, Robert
Likic, Robert
author_facet Marcec, Robert
Likic, Robert
author_sort Marcec, Robert
collection PubMed
description
format Online
Article
Text
id pubmed-9307409
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-93074092022-07-25 Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients? Marcec, Robert Likic, Robert Clin Pharmacokinet Research Letter Springer International Publishing 2022-07-23 2022 /pmc/articles/PMC9307409/ /pubmed/35869361 http://dx.doi.org/10.1007/s40262-022-01154-x Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Letter
Marcec, Robert
Likic, Robert
Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?
title Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?
title_full Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?
title_fullStr Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?
title_full_unstemmed Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?
title_short Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?
title_sort could fluvoxamine dose de-escalation increase treatment compliance without sacrificing efficacy in covid-19 patients?
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307409/
https://www.ncbi.nlm.nih.gov/pubmed/35869361
http://dx.doi.org/10.1007/s40262-022-01154-x
work_keys_str_mv AT marcecrobert couldfluvoxaminedosedeescalationincreasetreatmentcompliancewithoutsacrificingefficacyincovid19patients
AT likicrobert couldfluvoxaminedosedeescalationincreasetreatmentcompliancewithoutsacrificingefficacyincovid19patients

Ejemplares similares